Latest Us Department Of Defense News

Bio-Gene Technology reports significant progress in developing its bio-insecticides Flavocide and Qcide, including new efficacy data and organic certification, positioning the company for growth amid rising global demand for safer pest control.

ReNerve Limited’s innovative NervAlign® Nerve Cuff has secured approval for use across the US Department of Defense and Veterans Affairs healthcare systems, marking a major milestone for the Australian medtech company.

Tungsten Mining has secured a listing on the US OTCQB exchange and launched a Denver office, marking a strategic push into North America’s critical minerals market.

St George Mining reports exceptional high-grade rare earth and niobium mineralisation at its Araxá Project in Brazil, alongside a strategic US partnership and a significant capital raise to fuel expansion.

Bio-Gene Technology Limited reports significant progress in Q1 FY26, unveiling new product opportunities and positive efficacy data, alongside securing US Department of Defense grants.

St George Mining showcased its Araxá rare earths and niobium project at EXPOSIBRAM 2025 in Brazil, highlighting strategic alliances with US processors and ongoing development progress. The company is positioning Araxá as a key non-China supply source amid shifting global rare earths dynamics.

xReality Group (XRG) has reported robust growth driven by its flagship Operator XR training system, securing a landmark $5.7 million contract with the Texas Department of Public Safety and unveiling ambitious plans for new product launches and global expansion.

xReality Group Limited delivered a record-breaking first quarter in FY26, driven by a landmark $5.7 million contract with the Texas Department of Public Safety and a rapidly growing US customer base.

Metal Powder Works Limited (MPW) has landed a $1 million contract with the US Navy for its innovative expeditionary DirectPowder™ unit, while expanding its alloy portfolio and customer base amid a $15 million capital raise.

EV Resources has entered a binding agreement to sell its Khartoum Project to Koba Resources for $700,000 cash plus a royalty, marking a strategic pivot towards its antimony assets and US critical minerals ambitions.

IperionX has boosted its titanium powder capacity by 60% with no extra capital, cutting unit costs to $55/kg, and is now accelerating a US Department of Defense-backed expansion to 1,400 tpa aiming for the lowest-cost titanium production in America.

Recce Pharmaceuticals reported a 21% increase in net loss to $21.4 million for FY2025, driven by intensified R&D spending. The company secured key regulatory approvals for Phase 3 trials of its lead anti-infective gel and bolstered its financial position with significant capital raises and grants.